Voluntary corporate emissions targets not enough to create real climate action
Imperial and CNRS strengthen UK-France science with new partnerships
New AI startup accelerator led by Imperial opens for applications
A unique, internationally-recognised portfolio of translational research in neuroscience and mental health.
Top Links
A new company using research from the Department of Brain Sciences will look for drugs to treat brain cancers and diseases of old age.
Dame Professor Carol Black, who led the government’s independent review on drugs, visited the Division of Psychiatry's addiction research group.
New research shows that weekly epigenetic treatment in mice can support spinal cord regeneration after severe injury.
Essential clock gene plays key role in neuroprotective pathways
16 April 2024
14 March 2024
13 March 2024
29 April 2024, 10.00–16.00
Imperial Lung and Airway Organoid Workshop